Eli Lilly said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the ...

An estimated 3.4 million Brits meet the criteria to receive a prescription for Wegovy and Mounjaro which would cost ...

The Prime Minister is set to give a mid-morning speech today unveiling plans to throw the weight of Whitehall behind AI in a ...

A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like ...

We have made this January "wellness month" here on the ABC7 and we are tackling a hot topic - weight loss drugs. The pros, cons and who can benefit.

There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...

Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.

McDonald's shares underperformed in 2024, likely due to the rise of GLP-1 medications. Learn why MCD stock is a Sell.

One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for weight loss, and major food conglomerates are trying to cater to their ...

The state attorney general has started cracking down on medical spas marketing unapproved versions of popular weight-loss ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Baby boomers and users of weight loss drugs suffering from “facial sagging” are flocking to injectable aesthetic treatments ...